Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of intravenous dexmedetomidine vs propofol/midazolam for continuous ICU sedation
2005-002541-39Phase 3Completed
- Sponsor
- Orion Corporation
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine (2 arms), sponsored by Orion Corporation. Primary endpoint: Primary efficacy variables. Started Jul 2005; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on 2005-002541-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002541-39.